Definium Therapeutics, Inc.
public$DFTX View Live Feed →
Total Raised
--
Contracts
--
Patents
--
PAC Giving
--
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
No recent news or market intelligence found for this entity.
Congressional Trades in $DFTX
No disclosed congressional trades found in $DFTX.
Insider Trades (Form 4)
OPTION_EXERCISEDirector
Vallone Carol A
$38,5751,086 shares Sep 19, 2026
OPTION_EXERCISEDirector
Krebs Andreas
$57,8621,629 shares Sep 19, 2026
SELLChief Executive Officer
Barrow Robert
$721,73359,023 shares Sep 5, 2026
GRANTChief Executive Officer
Barrow Robert
375,000 shares Aug 12, 2026
GRANTChief Medical Officer
Karlin Daniel
100,000 shares Aug 12, 2026
GRANTChief Legal Officer
Sullivan Mark
62,500 shares Aug 12, 2026
GRANTChief Commercial Officer
Wiley Matthew T.
62,500 shares Aug 12, 2026
GRANTChief Financial Officer
Roberts Brandi
62,500 shares Aug 12, 2026
Key People
Krebs Andreas
Director
BoardInsider
Karlin Daniel
Chief Medical Officer
Insider
Barrow Robert
Chief Executive Officer
BoardInsider
Roberts Brandi
Chief Financial Officer
Insider
Wiley Matthew T
Chief Commercial Officer
Insider
Sullivan Mark
Chief Legal Officer
Insider
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro